Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

VORTIOXETINE HYDROBROMIDE vs VUTRISIRAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

VORTIOXETINE HYDROBROMIDE vs VUTRISIRAN: Safety Overview

Metric VORTIOXETINE HYDROBROMIDE VUTRISIRAN
Total FAERS Reports 13,705 1,425
Deaths Reported 400 321
Death Rate 2.9% 22.5%
Hospitalizations 1,741 550
Average Patient Age 48.8 yrs 72.2 yrs
% Female Patients 69.5% 31.3%
FDA Approval Date Sep 30, 2013 Jun 13, 2022
Manufacturer Takeda Pharmaceuticals America, Inc. Alnylam Pharmaceuticals, Inc.
Route ORAL SUBCUTANEOUS
Marketing Status Prescription Prescription